M. Nyati

发表

Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE) A Randomized, Open-Label, Clinical Trial

D. Moodley, L. Mofenson, G. Theron, 2017, Journal of acquired immune deficiency syndromes.

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

B. Chi, D. Moodley, G. Theron, 2022, BMC Infectious Diseases.

Effects of long-term antiretroviral therapy in reproductive-age women in sub-Saharan Africa (the PEPFAR PROMOTE study): a multi-country observational cohort study.

M. Fowler, T. Chipato, L. Stranix-Chibanda, 2022, The lancet. HIV.

Neurodevelopmental outcomes of HIV/antiretroviral drug perinatally exposed uninfected children aged 3–6 years

M. Fowler, T. Chipato, L. Stranix-Chibanda, 2022, AIDS.

Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency Virus

G. Montepiedra, G. Theron, T. Chipato, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Plasma and Intracellular Tenofovir Pharmacokinetics in the Neonate (ANRS 12109 Trial, Step 2)

F. Dabis, S. Urien, D. Ekouevi, 2011, Antimicrobial Agents and Chemotherapy.

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Ana C. Matos, C. Königs, C. Giaquinto, 2022, The lancet. HIV.

Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping

G. Montepiedra, T. Sterling, D. Haas, 2020, Clinical pharmacology and therapeutics.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Ana C. Matos, C. Königs, J. Seeley, 2022, The lancet. HIV.

Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection

S. Raitt, L. Mofenson, J. Klausner, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Frequent Genital HSV-2 Shedding among Women during Labor in Soweto, South Africa

A. Wald, L. Corey, G. Gray, 2014, Infectious diseases in obstetrics and gynecology.

Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component

Ingrid A. Beck, D. Moodley, L. Mofenson, 2021, Journal of acquired immune deficiency syndromes.

Support for relactation among mothers of HIV-infected children: a pilot study in Soweto.

L. Kuhn, G. Gray, A. Goga, 2014, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the Globe

L. Aurpibul, J. Currier, M. Fowler, 2019, AIDS and Behavior.

Very High Concentrations of Active Intracellular Phosphorylated Emtricitabine in Neonates (ANRS 12109 Trial, Step 2)

F. Dabis, S. Urien, G. Gray, 2011, Antimicrobial Agents and Chemotherapy.

Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial

G. Montepiedra, L. Mokgatlhe, W. El-Sadr, 2023, BMC Pregnancy and Childbirth.

The multi-country PROMOTE HIV antiretroviral treatment observational cohort in Sub-Saharan Africa: Objectives, design, and baseline findings

M. Fowler, T. Chipato, T. Taha, 2018, PloS one.

Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinic

J. Blackstone, E. Williams, C. Giaquinto, 2023, EClinicalMedicine.

Unintended pregnancy and contraception use among African women living with HIV: Baseline analysis of the multi-country US PEPFAR PROMOTE cohort

J. Aizire, Sufia Dadabhai, S. Hanley, 2024, PLoS ONE.

Plasma and Intracellular Tenofovir Pharmacokinetics in the Neonate (ANRS 12109 Trial, Step 2)

F. Dabis, S. Urien, D. Ekouevi, 2011, Antimicrobial Agents and Chemotherapy.